Parameters Associated with Chronic Spontaneous Urticaria Duration and Severity: A Systematic ReviewRabelo-Filardi R.a · Daltro-Oliveira R.a · Campos R.A.a, b
aUniversidade Federal da Bahia, and bServiço de Imunologia, Hospital das Clínicas Professor Edgard Santos, Salvador, Brazil
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Background: Although some authors have already evaluated the predictive value of various parameters regarding the duration of chronic spontaneous urticaria (CSU), it remains uncertain which ones have importance in clinical practice as prognostic factors that indeed enable prediction. Similarly, some authors have investigated parameters that might be related to severe cases of CSU. However, the results of studies evaluating several parameters as markers of disease severity are fragmented. Thus, we performed a systematic review to summarize the findings of studies investigating the parameters associated with CSU duration and severity. Methods: Two authors independently searched PubMed until June 2012 for observational retrospective or prospective studies addressing clinical or laboratory parameters associated with disease duration or severity in CSU patients. Results: We found 1,136 potentially relevant published papers related to the subject, 34 of which were included in the systematic review. A total of 16, 6 and 12 articles evaluated CSU parameters on severity, duration or both, respectively. Conclusions: Our findings suggest that disease severity might predict CSU duration. Similarly, evidence suggests that plasma levels of prothrombin fragment 1 + 2, D-dimer and C-reactive protein may function as markers of CSU severity.
© 2013 S. Karger AG, Basel
- Zuberbier T, Asero R, Bindslev-Jensen C, Walter Canonica G, Church MK, Gimenez-Arnau A, Grattan CE, Kapp A, Merk HF, Rogala B, Saini S, Sanchez-Borges M, Schmid-Grendelmeier P, Schunemann H, Staubach P, Vena GA, Wedi B, Maurer M: EAACI/GA(2)LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria. Allergy 2009;64:1417-1426.
- Kulthanan K, Jiamton S, Gorvanich T, Pinkaew S: Autologous serum skin test in chronic idiopathic urticaria: prevalence, correlation and clinical implications. Asian Pac J Allergy Immunol 2006;24:201-206.
- Kurt E, Aktas A, Aksu K, Keren M, Dokumacioglu A, Goss CH, Alatas O: Autologous serum skin test response in chronic spontaneous urticaria and respiratory diseases and its relationship with serum interleukin-18 level. Arch Dermatol Res 2011;303:643-649.
- George M, Balachandran C, Prabhu S: Chronic idiopathic urticaria: comparison of clinical features with positive autologous serum skin test. Indian J Dermatol Venereol Leprol 2008;74:105-108.
- Toubi E, Kessel A, Avshovich N, Bamberger E, Sabo E, Nusem D, Panasoff J: Clinical and laboratory parameters in predicting chronic urticaria duration: a prospective study of 139 patients. Allergy 2004;59:869-873.
- Vohra S, Sharma NL, Mahajan VK, Shanker V: Clinicoepidemiologic features of chronic urticaria in patients having positive versus negative autologous serum skin test: a study of 100 Indian patients. Indian J Dermatol Venereol Leprol 2011;77:156-159.
- Nebiolo F, Bergia R, Bommarito L, Bugiani M, Heffler E, Carosso A, Castiglioni G, Guida G, Badiu I, Pizzimenti S, Mietta S, Ferrero N, Rolla G: Effect of arterial hypertension on chronic urticaria duration. Ann Allergy Asthma Immunol 2009;103:407-410.
- Nettis E, Dambra P, D'Oronzio L, Cavallo E, Loria MP, Fanelli M, Ferrannini A, Tursi A: Reactivity to autologous serum skin test and clinical features in chronic idiopathic urticaria. Clin Exp Dermatol 2002;27:29-31.
- Alyasin S, Hamidi M, Karimi AA, Amiri A, Ghaffarpasand F, Ehsaei MJ: Correlation between clinical findings and results of autologous serum skin test in patients with chronic idiopathic urticaria. South Med J 2011;104:111-115.
- Kocaturk E, Kavala M, Kural E, Sarigul S, Zindanci I: Autologous serum skin test versus autologous plasma skin test in patients with chronic urticaria: evaluation of reproducibility, sensitivity and specificity and relationship with disease activity, quality of life and anti-thyroid antibodies. Eur J Dermatol 2011;21:339-343.
- Sahiner UM, Civelek E, Tuncer A, Yavuz ST, Karabulut E, Sackesen C, Sekerel BE: Chronic urticaria: etiology and natural course in children. Int Arch Allergy Immunol 2011;156:224-230.
- Sajedi V, Movahedi M, Aghamohamadi A, Ghareguzlou M, Shafiei A, Soheili H, Sanajian N: Comparison between sensitivity of autologous skin serum test and autologous plasma skin test in patients with chronic idiopathic urticaria for detection of antibody against IgE or IgE receptor (FcεRIα). Iran J Allergy Asthma Immunol 2011;10:111-117.
- Staubach P, Onnen K, Vonend A, Metz M, Siebenhaar F, Tschentscher I, Opper B, Ma-gerl M, Ludtke R, Kromminga A, Maurer M: Autologous whole blood injections to patients with chronic urticaria and a positive autologous serum skin test: a placebo-controlled trial. Dermatology 2006;212:150-159.
- Sabroe RA, Grattan CE, Francis DM, Barr RM, Kobza Black A, Greaves MW: The autologous serum skin test: a screening test for autoantibodies in chronic idiopathic urticaria. Br J Dermatol 1999;140:446-452.
- Asero R, Lorini M, Chong SU, Zuberbier T, Tedeschi A: Assessment of histamine-releasing activity of sera from patients with chronic urticaria showing positive autologous skin test on human basophils and mast cells. Clin Exp Allergy 2004;34:1111-1114.
- Gangemi S, Saitta S, Lombardo G, Patafi M, Benvenga S: Serum thyroid autoantibodies in patients with idiopathic either acute or chronic urticaria. J Endocrinol Invest 2009;32:107-110.
- Kessel A, Helou W, Bamberger E, Sabo E, Nusem D, Panassof J, Toubi E: Elevated serum total IgE - a potential marker for severe chronic urticaria. Int Arch Allergy Immunol 2010;153:288-293.
- Breneman D, Bronsky EA, Bruce S, Kalivas JT, Klein GL, Roth HL, Tharp MD, Treger C, Soter N: Cetirizine and astemizole therapy for chronic idiopathic urticaria: a double-blind, placebo-controlled, comparative trial. J Am Acad Dermatol 1995;33:192-198.
- Magen E, Mishal J, Zeldin Y, Feldman V, Kidon M, Schlesinger M, Sthoeger Z: Increased mean platelet volume and C-reactive protein levels in patients with chronic urticaria with a positive autologous serum skin test. Am J Med Sci 2010;339:504-508.
- Lee HC, Hong JB, Chu CY: Chronic idiopathic urticaria in Taiwan: a clinical study of demographics, aggravating factors, laboratory findings, serum autoreactivity and treatment response. J Formos Med Assoc 2011;110:175-182.
- Caproni M, Volpi W, Giomi B, Cardinali C, Antiga E, Melani L, Dagata A, Fabbri P: Chronic idiopathic and chronic autoimmune urticaria: clinical and immunopathological features of 68 subjects. Acta Derm Venereol 2004;84:288-290.
- Belot V, Desbois I, Martin L, Valat C, Lorette G, Machet L: Assessment of the usefulness of autologous serum skin testing in chronic urticaria: a retrospective single-centre study of 74 patients. Ann Dermatol Venereol 2010;137:444-450.
- Bajaj AK, Saraswat A, Upadhyay A, Damisetty R, Dhar S: Autologous serum therapy in chronic urticaria: old wine in a new bottle. Indian J Dermatol Venereol Leprol 2008;74:109-113.
- Takahagi S, Mihara S, Iwamoto K, Morioke S, Okabe T, Kameyoshi Y, Hide M: Coagulation/fibrinolysis and inflammation markers are associated with disease activity in patients with chronic urticaria. Allergy 2009;65:649-656.
- Asero R, Tedeschi A, Riboldi P, Cugno M: Plasma of patients with chronic urticaria shows signs of thrombin generation, and its intradermal injection causes wheal-and-flare reactions much more frequently than autologous serum. J Allergy Clin Immunol 2006;117:1113-1117.
- Sabroe RA, Fiebiger E, Francis DM, Maurer D, Seed PT, Grattan CE, Black AK, Stingl G, Greaves MW, Barr RM: Classification of anti-FcεRI and anti-IgE autoantibodies in chronic idiopathic urticaria and correlation with disease severity. J Allergy Clin Immunol 2002;110:492-499.
- Asero R, Tedeschi A, Coppola R, Griffini S, Paparella P, Riboldi P, Marzano AV, Fanoni D, Cugno M: Activation of the tissue factor pathway of blood coagulation in patients with chronic urticaria. J Allergy Clin Immunol 2007;119:705-710.
- Takeda T, Sakurai Y, Takahagi S, Kato J, Yoshida K, Yoshioka A, Hide M, Shima M: Increase of coagulation potential in chronic spontaneous urticaria. Allergy 2011;66:428-433.
- Asero R, Tedeschi A, Riboldi P, Griffini S, Bonanni E, Cugno M: Severe chronic urticaria is associated with elevated plasma levels of D-dimer. Allergy 2008;63:176-180.
- Tedeschi A, Asero R, Lorini M, Marzano AV, Cugno M: Plasma levels of matrix metalloproteinase-9 in chronic urticaria patients correlate with disease severity and C-reactive protein but not with circulating histamine-releasing factors. Clin Exp Allergy 2010;40:875-881.
- Tedeschi A, Lorini M, Suli C, Asero R: Serum interleukin-18 in patients with chronic ordinary urticaria: association with disease activity. Clin Exp Dermatol 2007;32:568-570.
- Sabroe RA, Seed PT, Francis DM, Barr RM, Black AK, Greaves MW: Chronic idiopathic urticaria: comparison of the clinical features of patients with and without anti-FcεRI or anti-IgE autoantibodies. J Am Acad Dermatol 1999;40:443-450.
- Altrichter S, Boodstein N, Maurer M: Matrix metalloproteinase-9: a novel biomarker for monitoring disease activity in patients with chronic urticaria patients? Allergy 2009;64:652-656.
- Kessel A, Bishara R, Amital A, Bamberger E, Sabo E, Grushko G, Toubi E: Increased plasma levels of matrix metalloproteinase-9 are associated with the severity of chronic urticaria. Clin Exp Allergy 2005;35:221-225.
- Baker R, Vasagar K, Ohameje N, Gober L, Chen SC, Sterba PM, Saini SS: Basophil histamine release activity and disease severity in chronic idiopathic urticaria. Ann Allergy Asthma Immunol 2008;100:244-249.
- Kulthanan K, Jiamton S, Thumpimukvatana N, Pinkaew S: Chronic idiopathic urticaria: prevalence and clinical course. J Dermatol 2007;34:294-301.
- Vonakis BM, Saini SS: New concepts in chronic urticaria. Curr Opin Immunol 2008;20:709-716.
- Maurer M, Weller K, Bindslev-Jensen C, Gimenez-Arnau A, Bousquet PJ, Bousquet J, Canonica GW, Church MK, Godse KV, Grattan CE, Greaves MW, Hide M, Kalogeromitros D, Kaplan AP, Saini SS, Zhu XJ, Zuberbier T: Unmet clinical needs in chronic spontaneous urticaria. A GA(2)LEN Task Force report. Allergy 2011;66:317-330.
- van der Valk PG, Moret G, Kiemeney LA: The natural history of chronic urticaria and angioedema in patients visiting a tertiary referral centre. Br J Dermatol 2002;146:110-113.
- Champion RH, Roberts SO, Carpenter RG, Roger JH: Urticaria and angio-oedema. A review of 554 patients. Br J Dermatol 1969;81:588-597.
- Asero R, Madonini E: Bronchial hyperresponsiveness is a common feature in patients with chronic urticaria. J Investig Allergol Clin Immunol 2006;16:19-23.
- Altrichter S, Peter HJ, Pisarevskaja D, Metz M, Martus P, Maurer M: IgE-mediated autoallergy against thyroid peroxidase - a novel pathomechanism of chronic spontaneous urticaria? PLoS One 2011;6:e14794.
- Magen E, Mishal J, Menachem S: Impact of contact sensitization in chronic spontaneous urticaria. Am J Med Sci 2011;341:202-206.
- Tedeschi A, Asero R, Marzano AV, Lorini M, Fanoni D, Berti E, Cugno M: Plasma levels and skin-eosinophil-expression of vascular endothelial growth factor in patients with chronic urticaria. Allergy 2009;64:1616-1622.
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.